Skip to content

CHECKPOINT THERAPEUTICS, INC.

CIK 0001651407

← back to feed
Revenue (TTM)
$138K
−60.2% YoY Q1 Mar 2025
Net Income (TTM)
−$38.55M
−8.5% YoY Q1 Mar 2025
EPS Diluted (TTM)
−$0.93
+55.2% YoY Q1 Mar 2025
Gross Margin
—
Q1 Mar 2025
Operating Margin
-27,894.2%
Q1 Mar 2025
Net Margin
-27,936.2%
Q1 Mar 2025
Free Cash Flow (TTM)
—
Q1 Mar 2025
Cash
$33.04M
Q1 Mar 2025
Total Debt
—
Q1 Mar 2025
Shares Outstanding
83.06M sh
Q1 Mar 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings